Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis

Multidrug-resistant (MDR) isolates of Mycobacterium tuberculosis (MTB) remain a primary global threat to the end of tuberculosis (TB) era. Delamanid (DLM) is a nitro-dihydro-imidazooxazole derivative utilized to treat MDR-TB. DLM has distinct mechanism of action, inhibiting methoxy- and keto-mycolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoshnood, Saeed, Taki, Elahe, Sadeghifard, Nourkhoda, Kaviar, Vahab Hassan, Haddadi, Mohammad Hossein, Farshadzadeh, Zahra, Kouhsari, Ebrahim, Goudarzi, Mehdi, Heidary, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529252/
https://www.ncbi.nlm.nih.gov/pubmed/34690963
http://dx.doi.org/10.3389/fmicb.2021.717045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529252/
https://www.ncbi.nlm.nih.gov/pubmed/34690963
http://dx.doi.org/10.3389/fmicb.2021.717045

Ejemplares similares